Docetaxel-loaded biomimetic nanoparticles for targeted lung cancer therapy in vivo

C Chi, F Li, H Liu, S Feng, Y Zhang, D Zhou… - Journal of Nanoparticle …, 2019 - Springer
Although the nanodrug-loading system provides new ideas for the effective treatment of
cancer, the lack of active cancer targeting, easy to be cleared by the reticuloendothelial …

[HTML][HTML] Dual receptor specific nanoparticles targeting EGFR and PD-L1 for enhanced delivery of docetaxel in cancer therapy

F Emami, R Duwa, A Banstola, SM Woo… - Biomedicine & …, 2023 - Elsevier
Dual-receptor targeted (DRT) nanoparticles which contain two distinct targeting agents may
exhibit higher cell selectivity, cellular uptake, and cytotoxicity toward cancer cells than single …

Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles

Q Liu, R Li, Z Zhu, X Qian, W Guan, L Yu… - International Journal of …, 2012 - Elsevier
To investigate the antitumor effect, biodistribution and penetration in tumors of docetaxel
(DOC)-loaded polyethylene glycol–poly (caprolactone)(mPEG–PCL) nanoparticles on …

Targeting docetaxel-PLA nanoparticles simultaneously inhibit tumor growth and liver metastases of small cell lung cancer

Z Liang, N Yang, Y Jiang, C Hou, J Zheng, J Shi… - International Journal of …, 2015 - Elsevier
Small cell lung cancer (SCLC) is one of the most malignant cancers in the world and 5-year
survival rate has not been significantly improved with conventional chemotherapy. Targeting …

Docetaxel-loaded novel nano-platform for synergistic therapy of non-small cell lung cancer

X Feng, X Xiong, S Ma - Frontiers in Pharmacology, 2022 - frontiersin.org
Nowadays, non-small cell lung cancer (NSCLC) is threatening the health of all mankind.
Although many progresses on treatment of lung cancer have been achieved in the past few …

The anti-tumor and immunomodulatory effects of PLGA-based docetaxel nanoparticles in lung cancer: the potential involvement of necroptotic cell death through …

P Gupta, A Singh, AK Verma, S Kant, AK Pandey… - Vaccines, 2022 - mdpi.com
Taxanes, microtubule stabilizing agents, are extensively used in the treatment of non-small
cell lung cancer (NSCLC). However, their clinical effectiveness remains restricted owing to …

Tumor-targeting, pH-sensitive nanoparticles for docetaxel delivery to drug-resistant cancer cells

TH Tran, T Ramasamy, JY Choi… - International journal …, 2015 - Taylor & Francis
The attachment of polyethylene glycol (PEG) increases the circulation time of drug-
containing nanoparticles; however, this also negatively affects cellular uptake. To overcome …

Transferrin-decorated protein-lipid hybrid nanoparticle efficiently delivers cisplatin and docetaxel for targeted lung cancer treatment

K Mao, W Zhang, L Yu, Y Yu, H Liu… - Drug Design …, 2021 - Taylor & Francis
Purpose Non-small cell lung cancer (NSCLC) therapy faces the barriers including drug
resistance. A transferrin-functionalized protein-lipid hybrid nanoparticle (PLHN) was …

[HTML][HTML] Docetaxel loaded PEG-PLGA nanoparticles: optimized drug loading, in-vitro cytotoxicity and in-vivo antitumor effect

MN Koopaei, MR Khoshayand… - Iranian journal of …, 2014 - ncbi.nlm.nih.gov
In this study a 3-factor, 3-level Box-Behnken design was used to prepare optimized
docetaxel (DTX) loaded pegylated poly lactide-co-glycolide (PEG-PLGA) Nanoparticles …

Tumour microenvironment-responsive lipoic acid nanoparticles for targeted delivery of docetaxel to lung cancer

F Gu, C Hu, Z Tai, C Yao, J Tian, L Zhang, Q Xia… - Scientific Reports, 2016 - nature.com
In the present study, we developed a novel type of reduction-sensitive nanoparticles (NPs)
for docetaxel (DTX) delivery based on cross-linked lipoic acid NPs (LANPs). The …